- Generic name
- Colistimethate Sodium
- Strength
- 1 MIU/vial
- Dosage form
- Injection
- Manufactured by
- Square Pharmaceuticals PLC.
Gigabac 1 M IV/IM Inj Injection
About Gigabac 1 M IV/IM Inj Injection
Gigabac 1 M IV/IM Inj is made by Square Pharmaceuticals PLC. It is a vial of 1 MIU/vial injection containing the antibacterial medicine Colistimethate Sodium, given by healthcare professionals for certain bacterial infections.
What is Gigabac 1 M IV/IM Inj Injection?
Gigabac 1 M IV/IM Inj is an injection supplied by Square Pharmaceuticals PLC. Each vial contains 1 MIU/vial of Colistimethate Sodium, which belongs to a group of antibacterial preparations. It is used to treat some acute or chronic infections caused by certain gram-negative bacteria, and it is used in particular for infections caused by sensitive strains of Pseudomonas aeruginosa. It is not meant for infections caused by Proteus or Neisseria. Because it is a hospital-type injection, a doctor or nurse gives it. The doctor decides whether it suits a particular infection and how it should be given.
Uses of Gigabac 1 M IV/IM Inj
Gigabac 1 M IV/IM Inj is used for acute or chronic infections caused by sensitive strains of certain gram-negative bacilli. It is particularly used for infections caused by sensitive strains of Pseudomonas aeruginosa. It does not treat infections due to Proteus or Neisseria. Only a doctor can confirm whether the infection is of a type this medicine can address, and the doctor decides the dose and course.
How to use Gigabac 1 M IV/IM Inj
Gigabac 1 M IV/IM Inj comes as a vial containing 1 MIU/vial of Colistimethate Sodium and is given by intravenous or intramuscular injection. A doctor or trained healthcare professional prepares and administers it, so patients should not attempt to use it themselves. The doctor sets the dose, the schedule and how long treatment continues, including any change needed for kidney problems. Ask the doctor or pharmacist about storage before and after the vial is prepared.
Side effects of Gigabac 1 M IV/IM Inj
Reported side effects include stomach upset, tingling of the hands, feet or tongue, slurred speech, dizziness, vertigo, numbness or unusual sensation, generalised itching, hives and rash, and fever. Changes in kidney-related blood tests, reduced urine output, breathing difficulty and pauses in breathing have also been reported. Tell the doctor promptly about any of these, and seek urgent help for breathing problems or greatly reduced urine output.
Safety and precautions
Tell the doctor before treatment if there is a history of allergy to Colistimethate Sodium or any ingredient of the injection. This medicine is used with caution in people with impaired kidney function, and the doctor may adjust the dose accordingly. It is also used with caution in newborns, infants and children. There are no adequate and well-controlled studies in pregnant women, and it crosses the placental barrier in humans, so it is used in pregnancy only if the benefit justifies the risk. It is not known whether it passes into breast milk, so nursing mothers should ask the doctor first.
Frequently asked questions
What does the generic name Colistimethate Sodium mean?
Colistimethate Sodium is the generic name of the active substance in the vial. It is an antibacterial medicine that acts on the bacterial cell membrane. Gigabac is the brand name under which Square Pharmaceuticals PLC supplies this injection.
What is Gigabac 1 M IV/IM Inj used for and what kind of medicine is it?
It is an antibacterial injection used for some acute or chronic infections caused by sensitive gram-negative bacteria, particularly Pseudomonas aeruginosa. It is not for infections due to Proteus or Neisseria. A doctor decides whether it is suitable for the infection.
What side effects should I watch for, and when should I call the doctor?
Watch for stomach upset, tingling, slurred speech, dizziness, itching, rash or fever. Call the doctor promptly about these. Seek urgent help for breathing difficulty, pauses in breathing or greatly reduced urine output, as these need immediate medical attention.
Who should ask a doctor before this injection is used?
People with kidney problems, a history of allergy to the medicine, pregnant women and nursing mothers should speak to the doctor first. Parents of newborns, infants and children should also ask the doctor. The doctor decides the dose, course and any needed adjustment.
Indications
Pharmacology
Dosage & Administration
Renal impairment patients: Dose adjustments in renal impairment patients are necessary. Dose reductions are recommended for patients with creatinine clearance < 50 ml/min. Twice daily dosing is recommended.
- Creatinine clearance <50-30 ml/min: daily dose 5.5-7.5 MIU
- Creatinine clearance <30-10 ml/min: daily dose 4.5-5.5 MIU
- Creatinine clearance <10 ml/min: daily dose 3.5 MIU
- No-HD days: 2.25 MIU/day (2.2-2.3 MIU/day).
- HD days: 3 MIU/day (Should be given after the HD session) Twice daily dosing is recommended.
- Children ≤40 kg: 75,000-150,000 IU/kg/day divided into 3 doses.
- Children >40 kg: >150,000 IU/kg/day has been reported in children with cystic fibrosis.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.